Navigation Links
Results For Phase 2b Trial Of Unique Investigational Cell-Based Therapy In Venous Leg Ulcers Published In The Lancet
Date:8/2/2012

enous ulcers fail to heal even after 3 months of standard treatment and develop into chronic, non-healing wounds. Based on an estimated figure of 2.5 million venous leg ulcers in the United States alone and a study of actual direct treatment costs of $9,685 per person, the annual cost of treating these wounds is likely in the many billions of dollars. Accordingly, the availability of innovative and more effective treatment strategies for such high-risk wounds could provide tremendous benefits to both patients and society.

About Healthpoint Biotherapeutics

Healthpoint Biotherapeutics is a biopharmaceutical company focused on the development and commercialization of novel, cost-effective solutions for dermal repair and regeneration. The company's research and development strategy is centered around next-generation bioactive therapies for the treatment of chronic wounds. Currently marketed products include Collagenase SANTYL® Ointment, OASIS® Wound Matrix, OASIS® Ultra Tri-Layer Matrix and REGRANEX® (becaplermin) Gel 0.01%. Healthpoint Biotherapeutics is also committed to advancing the care and treatment of wounds through support of industry leading continuing education from The Wound Institute®. To learn more about this comprehensive and award winning educational resource, please visit TheWoundInstitute.com®.  Healthpoint Biotherapeutics is a DFB Pharmaceuticals, Inc., affiliate company, and is based in Fort Worth, Texas. For more information, visit the company website at www.Healthpointbio.com.

HEALTHPOINT and related logo, SANTYL, THE WOUND INSTITUTE, THEWOUNDINSTITUTE.COM and REGRANEX are registered trademarks of Healthpoint, Ltd.

OASIS is a registered trademark of Cook Biotech, Inc.


'/>"/>
SOURCE Healthpoint Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
2. Cardica Announces Fiscal 2012 Fourth Quarter And Year End Financial Results
3. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
4. Cumberland Pharmaceuticals Reports Second Quarter 2012 Financial Results
5. IRIDEX Reports 2012 Second Quarter Results
6. Test Results Show Unprecedented Achievement for Marburg Drug Candidate
7. China Pharma Holdings, Inc. to Report Second Quarter of Fiscal Year 2012 Financial Results on August 15, 2012
8. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
9. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
10. Par Pharmaceutical Companies Reports Second Quarter 2012 Results
11. Henry Schein Reports Record Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 /PRNewswire/ ... destacado desarrollador y fabricante de herramientas de precisión ... y tratamiento de la enfermedad vascular periférica y ... ADVISE ( Ad enosine V asodilator ... II durante la sesión de ensayo clínico hot ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... Annual  Healthcare Conference on Thursday, May 30, 2013, at ... beginning at 9:20 a.m. Eastern Daylight Time. Arvind ... will present at the conference. Live audio of the presentation ... www.amgen.com , under Investors. A replay of the webcast ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... China, April 16, 2011 China Medical Equipment ... provider of ultrasound and MRI systems in China, ... portable ultrasound machine. The iuStar100 utilizes Samplify,s high-performance, ... SAM1600 analog to digital converter (ADC) to deliver ...
... Md., April 15, 2011 The U.S. Food and ... or in combination with methotrexate, for the treatment ... children ages 2 years and older. ... Still,s disease, is a rare, potentially life-threatening disorder ...
Cached Medicine Technology:United Imaging Healthcare Leverages Samplify's Analog Front-End Solutions to Deliver New Portable Ultrasound System with Superior Image Quality 2FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis 2FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis 3
(Date:5/24/2013)... Beach, Delaware (PRWEB) May 24, 2013 ... Mushrush has joined the Dayna Feher team at the ... Mushrush made the Delaware resorts her home in 1975. ... has since worked in all aspects of the real ... and for the past 12 years, a licensed sales ...
(Date:5/24/2013)... With Memorial Day Weekend upon us, cookout ... is offering tips to help prevent grill fires throughout the ... (NFPA) reports that gas grills led to an average ... other solid-fueled grills, meanwhile, caused approximately 1,200 home fires per ... Insurance is sharing the following tips from the NFPA to ...
(Date:5/24/2013)... -- New research suggests a link between sleep ... Every additional hour someone with insomnia sleeps ... the likelihood of moderate or high risk of ... Pennsylvania. "We were surprised by the ... suicide risk," study author, Linden Oliver, clinical research ...
(Date:5/24/2013)... Calif.) (PRWEB) May 24, 2013 ... House Appropriators and the California congressional delegation, joined ... restore sequestered industry user fees paid to the ... to ensure that future across-the-board cuts will not ... of the FY14 Agriculture, Rural Development and FDA ...
(Date:5/24/2013)... -- Drugs commonly used to treat glaucoma may cause ... with vision, according to a new study. The ... to reduce eye pressure, have already been shown to ... the researchers said, suggesting that the new findings could ... should be conservative when prescribing these drugs, the researchers ...
Breaking Medicine News(10 mins):Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2
... Safest, Most Fuel-Efficient Route and Protect Sensitive Medical Equipment as They Bring ... ... Calif. (Vocus) March 16, 2009 -- Applied Weather Technology (AWT) ... ships to deliver free, world-class health care services to the poor, recently ...
... faster by automating the admissions process with Web-based referral management software ... ... GA (PRWEB) March 16, 2009--Patient Placement System announced today the launch ... The Web-based service is an easy, low-cost software solution ...
... SHENZHEN, China, March 16 /PRNewswire-Aisia-FirstCall/ -- China Nepstar,Chain ... Nepstar" or the "Company"), the,largest drugstore chain in ... today announced that the Board of Directors has ... Share (ADS), or approximately,RMB250 million, which amounts to ...
... follows brain injury, researcher says, , , SUNDAY, March 15 ... drugs may prevent long-term damage from traumatic brain injury, ... Center researchers. , The drugs -- gamma-secretase inhibitors -- ... the brains of people with Alzheimer,s disease, according to ...
... carefully administered daily dose of peanuts has been so successful ... of children is now off treatment and eating peanuts daily, ... Hospital. , "It appears these children have lost their ... Pediatric Allergy and Immunology at Duke. "This gives other parents ...
... better than Lasik for individuals over 50. It Imparts distance and near ... cataracts, and does not induce dry eye. , ... Los Angeles, CA ... is better than Lasik for individuals over 50. It Imparts distance and ...
Cached Medicine News:Health News:Applied Weather Technology Guides Mercy Ships with Latest BVS Marine Voyage Optimization Software 2Health News:Applied Weather Technology Guides Mercy Ships with Latest BVS Marine Voyage Optimization Software 3Health News:Applied Weather Technology Guides Mercy Ships with Latest BVS Marine Voyage Optimization Software 4Health News:Applied Weather Technology Guides Mercy Ships with Latest BVS Marine Voyage Optimization Software 5Health News:Patient Placement Systems Announces Free 30-Day Trial Program for Referral Management System 2Health News:Patient Placement Systems Announces Free 30-Day Trial Program for Referral Management System 3Health News:China Nepstar Chain Drugstore Announces Dividend 2Health News:China Nepstar Chain Drugstore Announces Dividend 3Health News:Alzheimer's Drug May Someday Help Head Trauma Victims 2Health News:Studies show children can complete treatment for peanut allergies and achieve long-term tolerance 2Health News:Studies show children can complete treatment for peanut allergies and achieve long-term tolerance 3Health News:PRELEX is the Answer for Baby Boomers Vision Needs 2
... Biosensor's compact BioStress 2000 is a software ... Stress testing system. The BioStress 2000 program ... ECG viewing, permanent ECG strorage and retrieval ... any printer. BioStress 2000 allows a wide ...
Part of the Octopus System which includes both the Starfish & Octopus3. The Octopus3 Tissue Stabilizer is the pioneering and market-leading suction device....
... a simple way to lift the heart ... the XPOSE 3. The XPOSE 3 is ... off-pump bypass surgery and to easily position ... Designed for both apical and non-apical placement ...
... The CLEARGLIDE Optical Vessel Dissector has ... an operative cavity in the extraperitoneal spaces ... areas. The device may be used in ... The EVH system enables harvesting of a ...
Medicine Products: